glp 1 non injection GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients GLP-1 Agonists: A Comprehensive Overview

Induction and maintenance treatment with upadacitinib improves health-related quality of life in patients with moderately to severely active ulcerative colitis: phase 3 study results

Eloralintide is not FDA-approved and will not be available for years

Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019

Understanding this GLP-1 microbiome connection is the difference between viewing your symptoms as temporary discomfort that resolves on its own and recognizing persistent digestive dysfunction that requires targeted support

All these trials were designed to evaluate the primary outcome of 3-MACE defined as cardiovascular death, nonfatal myocardial infarct, and nonfatal stroke, except for the ELIXA trial of exenatide ER, which included hospitalization for unstable angina as an additional component of the 4-MACE composite outcomes